APELLIS PHARMACEUTICALS INC (APLS) Stock Cash Flow
NASDAQ:APLS - Nasdaq - US03753U1060 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -223.68M | -197.88M | -528.63M | -652.17M | -746.35M | |||
| Depreciation Amortization | 1.80M | 1.80M | 1.78M | 1.55M | 1.38M | |||
| Change In Working Capital | 95.70M | -18.08M | -200.17M | -15.70M | -93.52M | |||
| Interest Paid | 38.82M | 29.37M | 3.29M | 5.00M | 10.27M | |||
| Taxes Paid | 1.79M | 1.65M | 0.00 | 4.92M | N/A | |||
| Other non cash items | 117.89M | 126.30M | 132.28M | 152.57M | 275.37M | |||
| OPERATING CASH FLOW | -8.29M | -87.87M | -594.74M | -513.75M | -563.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -118.00K | -403.00K | -773.00K | -1.52M | -1.10M | |||
| Other Investing Activity | N/A | N/A | 99.00K | 61.42M | 248.72M | |||
| INVESTING CASH FLOW | -118.00K | -403.00K | -674.00K | 59.89M | 247.62M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 31.71M | -55.50M | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 9.63M | 18.83M | 461.04M | 405.84M | 398.02M | |||
| Other Financing Activity | -36.00K | 98.71M | -11.04M | -40.18M | -5.79M | |||
| FINANCING CASH FLOW | 41.30M | 149.24M | 394.50M | 365.66M | 392.24M | |||
| Exchange Rate Effect | -91.00K | -659.00K | 135.00K | -490.00K | -2.02M | |||
| CHANGE IN CASH | 32.80M | 60.31M | -200.78M | -88.69M | 74.71M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.29M | -87.87M | -594.74M | -513.75M | -563.13M | |||
| Capital Expenditure | -118.00K | -403.00K | -773.00K | -1.52M | -1.10M | |||
| FREE CASH FLOW | -8.41M | -88.27M | -595.51M | -515.27M | -564.23M | |||
All data in USD